# Theragenics

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/theragenics
Canonical HTML page: https://gethealthbrief.com/entity/theragenics

## Timeline

- **2027**: Phase III Milestones — Anticipated data readouts for TCT imaging agents supported by Cu-64 supply.
- **2026-Q4**: Supply Chain Integration — Integration of Theragenics' output into Clarity's clinical trial logistics.
- **2026-03-25**: Supply Agreement Signed — Clarity and Theragenics formalize large-scale Cu-64 manufacturing partnership.

## Recent coverage (1 stories)

### Clarity Pharmaceuticals Secures Scalable Cu-64 Supply via Theragenics Deal
2026-03-25 18:09:03 · Sentiment: Positive · Impact: 6/10 · Sources: 2

Clarity Pharmaceuticals has entered into a multi-year manufacturing supply agreement with Theragenics for the production of copper-64 (Cu-64). This partnership secures a reliable, large-scale supply of the isotope to support Clarity's clinical trials and future commercialization of its Targeted Copper Theranostics platform.
Full story: https://gethealthbrief.com/story/clarity-theragenics-cu64-supply-deal

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.